Managed care

ECFC Virtual Symposium Advances Healthcare Learnings from COVID-19 with Variety of Interactive Educational Sessions

Friday, July 30, 2021 - 8:28pm

The virtual Symposium will utilize the same user-friendly platform that was a success at the ECFC Annual Conference this past March.

Key Points: 
  • The virtual Symposium will utilize the same user-friendly platform that was a success at the ECFC Annual Conference this past March.
  • Our virtual Symposium is back and packed with three days of high quality and informative content our members need, said Christa Day, Executive Director for ECFC.
  • Virtual attendees will experience the same great offerings they have come to expect from our Symposium.
  • On August 5, the Symposium will feature an array of dynamic speakers and educational sessions including:
    All sessions will be recorded with attendee access to the sessions for 30 days after the Symposium.

NextGen Healthcare Fully Prevails in Hussein Trial Jury Verdict

Friday, July 30, 2021 - 7:29pm

As such, no adjustments are necessary to the Companys Q1FY22 financials, which were reported on July 29, 2021, just over an hour before the jury returned its verdict.

Key Points: 
  • As such, no adjustments are necessary to the Companys Q1FY22 financials, which were reported on July 29, 2021, just over an hour before the jury returned its verdict.
  • The Company will file its Quarterly Report on Form 10-Q today on Friday, July 30, 2021.
  • Please refer to the Q1F22 earnings release dated July 29, 2021 for Safe Harbor Provisions and Forward-Looking Statement.
  • NextGen Healthcare, Inc. (Nasdaq: NXGN) is a leading provider of ambulatory-focused technology solutions.

GEHA Extends Vaccination Incentive Program to Encourage U.S. COVID-19 Vaccinations

Friday, July 30, 2021 - 7:28pm

announced it will extend the previously launched COVID-19 Vaccination Incentive Program for GEHA medical plan members to September 6, 2021.

Key Points: 
  • announced it will extend the previously launched COVID-19 Vaccination Incentive Program for GEHA medical plan members to September 6, 2021.
  • GEHA members have the opportunity to secure both the GEHA incentive and their state and local governments depending on where they reside.
  • Extending the Vaccination Incentive Program is paramount to our commitment to our members and their families, said Interim President and CEO of GEHA Rich Bierman.
  • Eligible members are able to sign up for GEHAs COVID-19 Vaccination Incentive Program and submit proof of vaccination.

Glaucoma Epidemiology Forecasts to 2030: 10 Year Forecasts, 7MM Coverage, Total Prevalent Cases and Glaucoma Patients by Age Group - ResearchAndMarkets.com

Friday, July 30, 2021 - 9:58am

The total diagnosed prevalent population of Glaucoma in the 7MM was 10,104,188 in 2020 , which is expected to increase in the forecast period.

Key Points: 
  • The total diagnosed prevalent population of Glaucoma in the 7MM was 10,104,188 in 2020 , which is expected to increase in the forecast period.
  • Among the European five countries, Germany had the highest diagnosed prevalent population of Glaucoma with 1,042,465 cases, followed by Italy and France in 2020.
  • Among the major types of Glaucoma, i.e., open-angle and close-angle glaucoma, the former one accounts for a higher number of diagnosed Glaucoma cases.
  • The report provides the segmentation of the disease epidemiology for 7MM by Total Diagnosed Prevalence of Glaucoma, Type-specific Diagnosed Prevalent Population of Glaucoma, Gender-specific Diagnosed Prevalence of Glaucoma, Age-specific Diagnosed Prevalence of Glaucoma, Type-specific Diagnosed Prevalence of Open-Angle Glaucoma.

Stryker Sponsors the PGA TOUR’s 2021 World Golf Championships-FedEx St. Jude Invitational and Educates Fans on Joint Health

Friday, July 30, 2021 - 1:07pm

Stryker, one of the worlds leading medical technology companies, announced today that it will be a top 20 sponsor of the 2021 World Golf Championships-FedEx St. Jude Invitational.

Key Points: 
  • Stryker, one of the worlds leading medical technology companies, announced today that it will be a top 20 sponsor of the 2021 World Golf Championships-FedEx St. Jude Invitational.
  • Were excited to welcome Stryker and their Memphis-based foot and ankle business to the WGC-FedEx St. Jude Invitational, said Erin Stone, WGC-FedEx St. Jude Invitational tournament director.
  • Fans can stop by The Hub onsite at the tournament to learn more about joint health from the Stryker team through this interactive exhibit.
  • About the World Golf Championships-FedEx St. Jude Invitational
    The City of Memphis has held a PGA TOUR event every year since 1958, and 2021 will mark Memphis third year hosting a World Golf Championships event.

Owens & Minor Declares 3rd Quarter 2021 Dividend

Friday, July 30, 2021 - 11:45am

Owens & Minor, Inc. (NYSE: OMI) today announced that its Board of Directors have approved a third quarter 2021 dividend payment of $0.0025 per share, payable on September 30, 2021, to shareholders of record as of September 15, 2021.

Key Points: 
  • Owens & Minor, Inc. (NYSE: OMI) today announced that its Board of Directors have approved a third quarter 2021 dividend payment of $0.0025 per share, payable on September 30, 2021, to shareholders of record as of September 15, 2021.
  • A vertically-integrated, predominantly Americas-based footprint enables Owens & Minor to reliably supply its self-manufactured surgical and PPE products.
  • Operating continuously since 1882 from its headquarters in Richmond, Virginia, Owens & Minor has grown into a FORTUNE 500 company with operations located across North America, Asia, Europe and Latin America.
  • For more information about Owens & Minor, visit owens-minor.com, follow @Owens_Minor on Twitter and connect on LinkedIn at www.linkedin.com/company/owens-&-minor .

Innovative Community Oncology Practices Selects Deep Lens’ VIPER™ as Preferred Clinical Trial Matching Solution for Network

Friday, July 30, 2021 - 3:05pm

Deep Lens and the Innovative Community Oncology Practices ( ICOP ) today announced a strategic partnership that will position Deep Lens VIPER as the preferred clinical trial program management technology solution for the 13-practice, U.S.-based network.

Key Points: 
  • Deep Lens and the Innovative Community Oncology Practices ( ICOP ) today announced a strategic partnership that will position Deep Lens VIPER as the preferred clinical trial program management technology solution for the 13-practice, U.S.-based network.
  • VIPER is an artificial intelligence-based solution that matches eligible patients to clinical trials right at the time of diagnosis.
  • Through this agreement, VIPER and other Deep Lens services will become available to all ICOP practices.
  • Innovative Community Oncology Practices (ICOP) is a conglomerate of 13 oncology practices nationwide designed to increase the scope of services and activities in the community oncology setting.

Neighborhood Healthcare Celebrates Grand Opening of New Riverside Campus Developed in Partnership With Turner Impact Capital, Expanding Access to High-quality Healthcare

Friday, July 30, 2021 - 2:17am

The new campus was developed by Turner Impact Capital, a mission-driven social impact investment firm dedicated to tackling daunting societal challenges with sustainable, market-driven solutions.

Key Points: 
  • The new campus was developed by Turner Impact Capital, a mission-driven social impact investment firm dedicated to tackling daunting societal challenges with sustainable, market-driven solutions.
  • Turner Impact Capitals Turner Healthcare Facilities Fund (THFF) develops high-quality medical facilities for proven healthcare providers in communities with underserved patient populations.
  • Neighborhood Healthcare provides quality, compassionate, whole-person care to everyone, regardless of their circumstance, throughout San Diego and Riverside Counties.
  • Turner Impact Capital is the nations largest private equity real estate firm exclusively dedicated to social impact.

Humana Prices $3.0 Billion Debt Offering

Friday, July 30, 2021 - 12:41am

Humana Inc. (the company) (NYSE: HUM) announced today that it has priced a public offering of $3.0 billion in senior notes.

Key Points: 
  • Humana Inc. (the company) (NYSE: HUM) announced today that it has priced a public offering of $3.0 billion in senior notes.
  • The company expects net proceeds from the Senior Notes Offerings will be approximately $2.973 billion, after deducting underwriters discounts and estimated offering expenses.
  • This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995.
  • Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health.

Good Neighbor Pharmacy Hosts Virtual ThoughtSpot 2021 Conference & Trade Show

Thursday, July 29, 2021 - 8:26pm

Today, AmerisourceBergen and Good Neighbor Pharmacy kicked off the final day of ThoughtSpot, Good Neighbor Pharmacys annual conference and trade show representing its commitment to supporting independent pharmacies as community healthcare destinations and providing resources to optimize their business operations.

Key Points: 
  • Today, AmerisourceBergen and Good Neighbor Pharmacy kicked off the final day of ThoughtSpot, Good Neighbor Pharmacys annual conference and trade show representing its commitment to supporting independent pharmacies as community healthcare destinations and providing resources to optimize their business operations.
  • Additionally, Mahaska Drug of Oskaloosa, IA was announced as the winner of the annual Good Neighbor Pharmacy of the Year award, honoring excellence in patient care, community outreach, and innovative pharmacy practice.
  • During todays final general session event, AmerisourceBergen leaders announced Good Neighbor Pharmacys four key objectives to help independent community pharmacies thrive in the year ahead:
    Also announced during ThoughtSpot was Good Neighbor Pharmacys recent ranking on the J.D.
  • Our customers not only rose to the challenge but went above and beyond for their communities, said Brian Nightengale, RPh, PhD, President of Good Neighbor Pharmacy.